Foamix pharmaceuticals ltd. (FOMX)
Balance Sheet / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Jun'17Dec'16Jun'16Dec'15Jun'15Dec'14Dec'13
Assets
CURRENT ASSETS:
Cash and cash equivalents

43,759

40,534

39,085

18,994

27,868

87,877

11,702

12,770

15,956

45,827

31,190

20,006

18,795

34,956

43,008

1,747

Restricted cash

825

250

250

250

250

250

250

250

250

250

250

-

0

-

-

-

Short term bank deposits

12,102

19,141

16,187

24,155

24,047

6,099

19,632

6,043

19,443

21,328

38,351

28,123

13,107

13,075

0

-

Investment in marketable securities (Note 4)

16,246

15,333

14,091

39,122

46,669

15,041

22,831

28,578

31,797

30,733

43,275

27,203

23,693

-

6,958

561

Restricted investment in marketable securities (Note 4)

434

288

282

276

268

277

275

286

290

-

-

-

-

-

-

-

Restricted investment in marketable securities (Note 4)

-

-

-

-

-

-

-

-

-

287

261

954

769

-

0

0

Investment in available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

17,624

-

-

Trade receivable

135

-

308

1,168

1,066

889

975

846

996

798

3,236

754

314

135

495

425

Other (Note 13a)

1,557

979

1,511

1,209

999

1,624

491

424

772

531

438

373

471

598

430

162

Inventory (Note 5)

1,356

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL CURRENT ASSETS

76,414

76,525

71,714

85,174

101,167

112,057

56,156

49,197

69,504

99,754

117,001

77,413

57,149

66,388

50,891

2,895

NON-CURRENT ASSETS:
Investment in marketable securities (Note 4)

-

-

-

-

150

793

1,572

5,054

8,533

10,959

17,532

14,600

32,285

-

0

-

Restricted investment in marketable securities (Note 4)

-

143

139

137

133

137

136

141

143

-

-

-

-

-

-

-

Restricted investment in marketable securities (Note 4)

-

-

-

-

-

-

-

-

-

142

129

-

0

-

104

-

Restricted investment in available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

796

-

-

Investment in available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

29,355

-

-

Investment in long term bank deposits

-

-

-

-

-

-

-

-

-

-

-

0

15,130

15,030

0

-

Property and equipment, net (Note 6)

2,885

2,809

2,497

2,297

2,235

2,157

2,166

2,045

2,042

1,497

938

796

646

320

248

62

Operating lease right of use assets (Note 7)

1,694

1,947

1,858

1,934

-

-

-

-

-

-

-

-

-

-

-

-

Other

166

159

18

17

46

43

44

32

32

35

35

35

35

36

34

129

TOTAL NON-CURRENT ASSETS

4,745

5,058

4,512

4,385

2,564

3,130

3,918

7,272

10,750

12,633

18,634

15,431

48,096

45,537

386

191

TOTAL ASSETS

81,159

81,583

76,226

89,559

103,731

115,187

60,074

56,469

80,254

112,387

135,635

92,844

105,245

111,925

51,277

3,086

Liabilities and shareholders' equity
CURRENT LIABILITIES:
Current maturities of bank borrowing (Note 8b)

-

-

-

-

-

-

-

-

-

5

20

32

31

32

31

0

Trade payables

19,352

7,357

9,434

5,657

6,327

5,322

12,357

8,186

6,436

7,127

2,267

1,342

1,353

679

626

89

Accrued expenses

3,381

-

-

-

351

-

-

-

-

-

-

-

-

-

-

-

Employee related obligations

5,231

-

-

-

3,498

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

0

0

0

62

-

0

0

29

0

35

991

Operating lease liabilities (Note 7)

1,092

1,136

999

914

-

-

-

-

-

-

-

-

-

-

-

-

Other

270

4,877

3,664

2,859

292

3,714

2,729

2,647

3,730

3,917

2,984

1,571

2,169

1,663

968

203

Loan from the BIRD foundation (Note 8a)

-

-

-

-

-

-

-

-

-

-

-

0

476

477

474

468

TOTAL CURRENT LIABILITIES

29,326

13,370

14,097

9,430

10,468

9,036

15,086

10,833

10,228

11,049

5,271

2,945

4,058

2,851

2,134

1,751

LONG-TERM LIABILITIES:
Convertible loans (Note 8b)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,549

Bank borrowing (Note 8c)

-

-

-

-

-

-

-

-

-

-

-

4

20

36

51

0

Liability for employee severance benefits (Note 8)

424

419

409

397

367

379

377

402

437

434

379

379

365

359

330

368

Operating lease liabilities (Note 7)

653

870

882

1,023

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt (Note 10)

32,725

12,939

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

456

456

456

714

714

714

714

890

988

-

0

-

-

-

-

-

TOTAL LONG-TERM LIABILITIES

34,258

14,684

1,747

2,134

1,081

1,093

1,091

1,292

1,425

434

379

383

385

395

381

4,917

TOTAL LIABILITIES

63,584

28,054

15,844

11,564

11,549

10,129

16,177

12,125

11,653

11,483

5,650

3,328

4,443

3,246

2,515

6,668

COMMITMENTS AND CONTINGENCIES (Note 9)

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

SHAREHOLDERS' EQUITY:
Ordinary Shares, NIS 0.16 par value - authorized: 135,000,000 and 90,000,000 Ordinary Shares as of December 31, 2019 and December 31, 2018; issued and outstanding: 61,580,544 and 54,351,140 Ordinary Shares as of December 31, 2019 and December 31, 2018, respectively

2,659

2,638

2,336

2,334

2,331

2,327

1,721

1,578

1,576

1,572

1,561

1,285

1,284

1,280

954

471

Additional paid-in capital

325,498

323,657

307,653

306,266

305,303

304,119

228,154

210,116

208,364

205,673

204,052

147,107

145,878

144,780

77,600

14,176

Accumulated deficit

-310,587

-272,767

-249,606

-230,613

-215,409

-201,331

-185,851

-167,223

-141,281

-106,337

-75,566

-58,931

-46,230

-37,445

-29,713

-18,229

Accumulated other comprehensive income (loss)

5

1

-1

8

-43

-57

-127

-127

-58

-4

-62

55

-130

64

-79

0

TOTAL SHAREHOLDERS' EQUITY

17,575

53,529

60,382

77,995

92,182

105,058

43,897

44,344

68,601

100,904

129,985

89,516

100,802

108,679

48,762

-3,582

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

81,159

81,583

76,226

89,559

103,731

115,187

60,074

56,469

80,254

112,387

135,635

92,844

105,245

111,925

51,277

3,086